Written Question·Department of Health and Social Care·UIN 127170
Neuroendocrine Cancer: Medical Treatments
Tabled: 14 April 2026
Answered: 20 April 2026
Named DayQuestion
Manuela Perteghella
Liberal Democrat — Stratford-on-Avon
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of patient access to specialist treatments for neuroendocrine cancer, including peptide receptor radionuclide therapy.
Answer
Mrs Sharon HodgsonImproving the early diagnosis of rare cancers, including neuroendocrine cancers, is a priority for the Government. In February, the Government published the first ever National Cancer Plan with a dedicated chapter on rare cancers.The Government is committ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 127170) →